Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,754.50
Bid: 1,754.50
Ask: 1,755.00
Change: 24.50 (1.42%)
Spread: 0.50 (0.028%)
Open: 1,735.50
High: 1,759.50
Low: 1,735.00
Prev. Close: 1,730.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London close: Stocks jump to four-week high as Syria concerns ease

Tue, 10th Sep 2013 16:40

The FTSE 100 jumped to a four-week high on Tuesday as investors' fears of an impending US military strike on Syria eased and the economic outlook for China improved.London's benchmark index finished 53.25 points higher at 6,583.99, a gain of 0.82%; the last time it closed higher was on August 14th when it ended the day at 6,587.43."The FTSE 100 is knocking on the door of 6,600 for the first time since mid-August, as investors look to make gains before the crucial Fed meeting next week," said Market Analyst Chris Beauchamp from IG. Friday's disappointing US non-farm payrolls figure has increased hopes that the Federal Reserve could delay a move to taper its stimulus programme until later this year.Markets started on the front foot this morning on the back of a continuing improvement in economic data from China with the third-quarter outlook for the Asian powerhouse continuing to brighten. Industrial output, fixed-asset investment and retail sales strengthened during the month of August, with all three economic indicators rising by more than expected. This followed yesterday's news that exports rose more than expected in August, while consumer price inflation eased.Stocks then extended gains in the afternoon as Wall Street indices reacted positively to developments in Syria, with the S&P 500 extending its recent winning streak into the sixth day, its longest string of positive sessions since mid-July.Positive developments in SyriaSyria said today that it has accepted a Russian-backed proposal to give up chemical weapons to international control in an attempt to avoid US military action, according to Russian news agency Interfax. This follows the request by Russian Foreign Minister Sergei Lavrov yesterday to give up any chemical weapons they may.Syria's Foreign Minister Walid Muallem said that he agreed to the proposals to "remove the grounds for American aggression".IG's Beauchamp said: "If you'd been asked to suggest a possible starting point for a solution to the Syrian crisis, I suspect Russia would not have been at the top of the list. "Nevertheless, it now seems as if Moscow could find a way to take some of the heat out of the situation. As a result, markets have breathed a sigh of relief, with stock indices gaining and gold and oil giving back much of their recent gains."All eyes now turn to US President Barack Obama ahead of a speech in Washington tonight where he is expected to outline his intentions for the next course of action regarding Syria.FTSE 100: Airlines flying high, miners track metals lowerAirline groups IAG and easyJet were flying higher with crude continuing to pull back from its recent highs as fears over turmoil in the Middle East ease. Elevated oil prices have pressured both stocks over the last few weeks on concerns over the knock-on effects to jet fuel costs. Shares in easyJet were also helped by comments from Chief Executive Carolyn McCall who said in an interview that the company will be "Europe's preferred airline in five years' time" due to its low-cost operating model.easyJet rose yesterday after Bank of America Merrill Lynch predicted that October's fourth-quarter trading update would see a continuation of its robust yield performance, and suggested a special dividend could also be on the cards. Monday also saw the company add two new routes, with seats to go on sale from next month.Financials were also performing well today with RBS, Standard Chartered, Aberdeen Asset Management, Prudential, Hargreaves Lansdown and Aviva among the highest risers.Leading the downside were the miners as metal prices fell across the board. Precious metals peers Randgold and Fresnillo were among the worst performers as gold futures dropped to a two-week low. Recently-merged Glencore Xstrata however bucked the trend after lifting its synergy target to at least $2bn next year as the miner vowed to cut costs and improve operational efficiency. Pharma giant GlaxoSmithKline fell sharply after US regulators set out requirements for generic versions of its lung drug Advair, sparking competition concerns over when patents run out in a few years' time.Costa and Premier Inn owner Whitbread was also down after seeing sales growth slow from 13.8% in the first quarter to just 10.8% in the second as the hot summer weather hit demand at its coffee shops.Broker comments were also moving a number of blue-chip stocks: Drinks giant SABMiller was on the climb this morning after HSBC upgraded the stock to 'overweight'; consumer products group Unilever was lifted by Deutsche Bank to 'buy'; and Babcock was higher after JPMorgan labelled the engineering support services company as its top pick in the sector.FTSE 250: Ashmore jumps, Oxford Instruments slumpsRecord subscriptions helped emerging markets asset manager Ashmore to drive strong net inflows into its funds in the year to June, giving the share price a boost this morning. Strong net inflows of $13.4bn led to a 22% increase in assets under management (AuM) to $77.4bn during the year, with average AuM rising 13%.Oxford Instruments was a heavy faller after saying that while growth in the order intake rate in Industrial Products and third party Service is encouraging, slowness in R&D markets in the Western economies means that the year is likely to be more second half-weighted.Shares in chip designer Imagination Technologies jumped today ahead of an Apple event in California where the tech giant - a key customer for Imagination - is expected to unveil its latest iPhone.FTSE 100 - RiserseasyJet (EZJ) 1,358.00p +7.18%Royal Bank of Scotland Group (RBS) 356.00p +4.71%International Consolidated Airlines Group SA (CDI) (IAG) 319.80p +4.68%Carnival (CCL) 2,450.00p +4.26%Aberdeen Asset Management (ADN) 384.10p +4.04%Standard Chartered (STAN) 1,511.00p +3.81%Legal & General Group (LGEN) 199.60p +2.99%Prudential (PRU) 1,171.00p +2.99%SABMiller (SAB) 3,174.00p +2.88%Weir Group (WEIR) 2,344.00p +2.85%FTSE 100 - FallersRandgold Resources Ltd. (RRS) 4,689.00p -4.58%Fresnillo (FRES) 1,225.00p -3.47%GlaxoSmithKline (GSK) 1,598.50p -2.53%Whitbread (WTB) 3,138.00p -2.43%Eurasian Natural Resources Corp. (ENRC) 221.00p -1.69%Vodafone Group (VOD) 207.90p -1.19%BG Group (BG.) 1,205.00p -0.99%Rolls-Royce Holdings (RR.) 1,131.00p -0.26%Tullow Oil (TLW) 1,057.00p -0.19%Vedanta Resources (VED) 1,188.00p -0.17%FTSE 250 - RisersAshmore Group (ASHM) 382.20p +5.32%Imagination Technologies Group (IMG) 302.00p +5.19%Fenner (FENR) 389.50p +5.01%Laird (LRD) 234.70p +4.96%Ferrexpo (FXPO) 187.00p +4.64%Galliford Try (GFRD) 1,070.00p +4.59%Henderson Group (HGG) 187.10p +4.53%Synthomer (SYNT) 249.20p +4.40%Ocado Group (OCDO) 365.00p +4.29%Greggs (GRG) 438.70p +4.15%FTSE 250 - FallersAfrican Barrick Gold (ABG) 166.40p -9.37%Oxford Instruments (OXIG) 1,404.00p -7.02%Moneysupermarket.com Group (MONY) 168.50p -2.21%Pace (PIC) 280.50p -2.13%Centamin (DI) (CEY) 46.00p -1.96%International Personal Finance (IPF) 640.00p -1.54%Polymetal International (POLY) 756.00p -1.50%Essar Energy (ESSR) 136.70p -1.37%RPS Group (RPS) 257.00p -1.19%ITE Group (ITE) 288.50p -1.13%BC
More News
26 Feb 2024 08:25

GSK gonorrhoea treatment achieves efficacy endpoint in latest trial

(Alliance News) - GSK PLC on Monday announced positive results from the latest trial of its oral gonorrhoea treatment, showing it to be on par with intramuscular therapies.

Read more
26 Feb 2024 07:22

GSK reports positive results from gonorrhoea treatment trial

(Sharecast News) - GSK announced encouraging headline outcomes from its trial of gepotidacin, an oral antibiotic aiming to address uncomplicated urogenital gonorrhoea in adolescents and adults, on Monday.

Read more
21 Feb 2024 09:47

GSK reports encouraging results for ViiV's Cabenuva HIV treatment

(Alliance News) - GSK PLC on Wednesday said that its majority-owned company ViiV Healthcare had received positive interim data from ongoing trials of its injectable HIV treatment.

Read more
21 Feb 2024 07:22

GSK's ViiV sees success in latest HIV treatment trial

(Sharecast News) - GSK's specialist HIV unit ViiV Healthcare, which it owns in partnership with Pfizer and Shionogi, unveiled promising findings from the 'LATITUDE' phase three trial of its long-acting injectable HIV treatment Cabenuva on Wednesday.

Read more
20 Feb 2024 15:10

PRESS: AJ Bell founder to join Applied Nutrition ahead of IPO - Sky

(Alliance News) - Supplements maker Applied Nutrition, plotting a London stock market float, is to add AJ Bell PLC founder Andy Bell as its chair, Sky News reported on Tuesday.

Read more
20 Feb 2024 08:55

IN BRIEF: Diageo welcomes GSK's CFO as non-executive director

Diageo PLC - London-based brewer and distiller sells more than 200 drinks brands, including Guinness stout, Captain Morgan rum and Johnnie Walker whisky - Appoints GSK PLC's chief financial officer and executive director, Julie Brown, as a non-executive director. Says she will succeed Alan Stewart as chair of the audit committee after his retirement following the firm's annual general meeting in September. Chair Javier Ferran says: "Julie brings many years of experience in financial, commercial and strategic roles in international companies operating in highly regulated industries. She is strongly committed to enabling diversity in business and to creating sustainable, long-term value for stakeholders. I look forward to her contribution to Board discussions and to working with her in progressing Diageo's ambition to be one of the most trusted and respected consumer products companies in the world."

Read more
15 Feb 2024 14:44

UK dividends calendar - next 7 days

Friday 16 February 
JPMorgan Asia Growth & Income PLCdividend payment date
JPMorgan Japan Small Cap Growth & Income PLCdividend payment date
Murray International Trust PLCdividend payment date
Premier Miton Group PLCdividend payment date
Schroder Oriental Income Funddividend payment date
Solid State PLCdividend payment date
Monday 19 February 
no events scheduled 
Tuesday 20 February 
Invesco Bond Income Plus Ltd 
Wednesday 21 February 
no events scheduled 
Thursday 22 February 
abrdn Asia Focus PLCex-dividend payment date
Alumasc Group PLCex-dividend payment date
AstraZeneca PLCex-dividend payment date
BlackRock Throgmorton Trust PLCex-dividend payment date
Braemar PLCex-dividend payment date
easyJet PLCex-dividend payment date
Ecofin US Renewables Infrastructure Trust PLCex-dividend payment date
Endeavour Mining PLCex-dividend payment date
FRP Advisory Group PLCex-dividend payment date
Gateley Holdings PLCex-dividend payment date
GSK PLCex-dividend payment date
Hercules Site Services PLCex-dividend payment date
Jersey Electricity PLCex-dividend payment date
Land Securities Group PLCex-dividend payment date
Molten Ventures VCT PLCex-dividend payment date
Northern Bear PLCex-dividend payment date
Redrow PLCex-dividend payment date
Samuel Heath & Sons PLCex-dividend payment date
Titon Holdings PLCex-dividend payment date
Unilever PLCex-dividend payment date
Van Elle Holdings PLCex-dividend payment date
Virgin Money UK PLCex-dividend payment date
Witan Investment Trust PLCex-dividend payment date
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
15 Feb 2024 11:02

Berenberg hikes target price on GSK

(Sharecast News) - Analysts at Berenberg hiked their target price on drugmaker GSK from £16.50 to £18.20 on Thursday, stating the group was moving closer to offsetting losses associated with the expiry of its patent on HIV drug dolutegravir.

Read more
15 Feb 2024 09:45

LONDON BROKER RATINGS: Jefferies cuts Kingfisher but Citi raises

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

Read more
15 Feb 2024 08:49

GSK completes USD1.4 billion purchase of respiratory firm Aiolos Bio

(Alliance News) - GSK PLC on Thursday said it has completed the acquisition of Aiolos Bio Ltd, expanding its respiratory portfolio with a potential "best-in-class" asthma treatment.

Read more
13 Feb 2024 16:53

LONDON MARKET CLOSE: Stocks in red amid sticky US inflation data

(Alliance News) - Stock prices in London closed in the red on Tuesday, after a key US inflation reading came in hotter-than-expected.

Read more
13 Feb 2024 16:21

London close: Stocks fall as US inflation tops expectations

(Sharecast News) - London markets ended the trading day in negative territory on Tuesday, influenced by concerns over higher inflation figures from the United States and a deceleration in wage growth within the UK.

Read more
13 Feb 2024 16:21

London close: Stocks fall as US inflation tops expectations

(Sharecast News) - London markets ended the trading day in negative territory on Tuesday, influenced by concerns over higher inflation figures from the United States and a deceleration in wage growth within the UK.

Read more
13 Feb 2024 12:06

LONDON MARKET MIDDAY: Stocks fall but pound up before US data

(Alliance News) - Stock prices in London were on the decline on Tuesday afternoon, with sentiment tetchy ahead of a US inflation report later.

Read more
13 Feb 2024 09:45

Citi ups recommendation on GSK to 'buy'

(Sharecast News) - Citi has upgraded its rating on vaccines and drugs blue chip GSK to 'buy' while also boosting its earnings estimates.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.